The company's stock closed at $14.25 in Friday's trading on Nasdaq. The discovery does not ensure that Agouron will …
La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening …
SmarTrend identified an Uptrend for La Jolla Pharm (NASDAQ:LJPC) on January 24th, 2018 at $33.81. In approximately 2 weeks, La Jolla Pharm has returned 15.87% as of today's recent price of $39.17. Over the past year, La Jolla Pharm …
Dec 4 (Reuters) - La Jolla Pharmaceutical Co: * LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES INITIATION …
La Jolla Pharmaceutical Company (OTCQB: LJPC) ("La Jolla"), a leader in the development of therapeutics targeting galectin proteins, announced today that the FDA Office of Orphan Products Development has granted an "Orphan Drug" …